Antimicrobial peptides with cell-penetrating peptide properties and vice versa
暂无分享,去创建一个
[1] W. Mark Saltzman,et al. Synthetic DNA delivery systems , 2000, Nature Biotechnology.
[2] A. Prochiantz,et al. The third helix of the Antennapedia homeodomain translocates through biological membranes. , 1994, The Journal of biological chemistry.
[3] R. Gust,et al. Specific labeling with potent radiolabels alters the uptake of cell‐penetrating peptides , 2009, Biopolymers.
[4] L. Chaloin,et al. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. , 1997, Nucleic acids research.
[5] Laszlo Otvos,et al. Antibacterial peptides and proteins with multiple cellular targets , 2005, Journal of peptide science : an official publication of the European Peptide Society.
[6] S. Henriques,et al. Consequences of nonlytic membrane perturbation to the translocation of the cell penetrating peptide pep-1 in lipidic vesicles. , 2004, Biochemistry.
[7] K. Hahm,et al. Biological activity of Tat (47-58) peptide on human pathogenic fungi. , 2006, Biochemical and biophysical research communications.
[8] H. G. Boman. Innate immunity and the normal microflora , 2000, Immunological reviews.
[9] R. Lehrer,et al. Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins , 1993, FEBS letters.
[10] Alan J. Waring,et al. Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils , 1998, Antimicrobial Agents and Chemotherapy.
[11] Y. Shai,et al. Mechanistic and Functional Studies of the Interaction of a Proline-rich Antimicrobial Peptide with Mammalian Cells* , 2006, Journal of Biological Chemistry.
[12] S. Shin,et al. Antimicrobial and Cytolytic Activities and Plausible Mode of Bactericidal Action of the Cell Penetrating Peptide Penetratin and Its Lys‐linked Two‐Stranded Peptide , 2009, Chemical biology & drug design.
[13] R. Gennaro,et al. Rapid membrane permeabilization and inhibition of vital functions of gram-negative bacteria by bactenecins , 1990, Infection and immunity.
[14] Kurt Ballmer-Hofer,et al. Antennapedia and HIV Transactivator of Transcription (TAT) “Protein Transduction Domains” Promote Endocytosis of High Molecular Weight Cargo upon Binding to Cell Surface Glycosaminoglycans* , 2003, Journal of Biological Chemistry.
[15] Christoph Patsch,et al. The FASEB Journal Research Communication Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells , 2022 .
[16] L. Otvos,et al. Antibacterial peptides isolated from insects. , 2000, Journal of peptide science : an official publication of the European Peptide Society.
[17] R. Gennaro,et al. Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes , 1994, FEBS letters.
[18] E. Eklund,et al. The Human Antimicrobial Peptide LL-37 Transfers Extracellular DNA Plasmid to the Nuclear Compartment of Mammalian Cells via Lipid Rafts and Proteoglycan-dependent Endocytosis* , 2004, Journal of Biological Chemistry.
[19] K. Brogden. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? , 2005, Nature Reviews Microbiology.
[20] M. Przybylski,et al. Amino acid sequences of two proline-rich bactenecins. Antimicrobial peptides of bovine neutrophils. , 1990, The Journal of biological chemistry.
[21] R. Hancock,et al. Peptide Antimicrobial Agents , 2006, Clinical Microbiology Reviews.
[22] L. Otvos,et al. An insect antibacterial peptide-based drug delivery system. , 2004, Molecular pharmaceutics.
[23] S. White,et al. Structure, location, and lipid perturbations of melittin at the membrane interface. , 2001, Biophysical journal.
[24] Rainer Fischer,et al. A Comprehensive Model for the Cellular Uptake of Cationic Cell‐penetrating Peptides , 2007, Traffic.
[25] G. Lindblom,et al. Charge-dependent translocation of the Trojan peptide penetratin across lipid membranes. , 2003, Biophysical journal.
[26] M. Pooga,et al. Cell penetration by transportan. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] M Bolognesi,et al. Structure and bactericidal activity of an antibiotic dodecapeptide purified from bovine neutrophils. , 1988, The Journal of biological chemistry.
[28] Huey W. Huang,et al. Action of antimicrobial peptides: two-state model. , 2000, Biochemistry.
[29] J. Larrick,et al. Antimicrobial activity of rabbit CAP18-derived peptides , 1993, Antimicrobial Agents and Chemotherapy.
[30] B. Wiesner,et al. Structural requirements for cellular uptake of alpha-helical amphipathic peptides. , 1999, Journal of Peptide Science.
[31] W. Anderson,et al. Human gene therapy. , 1992, Science.
[32] J. Wade,et al. Synthesis of a disulfide-linked octameric peptide construct carrying three different antigenic determinants. , 2001, Bioorganic & medicinal chemistry letters.
[33] P. Kinnunen,et al. Interaction of the antimicrobial peptide pheromone Plantaricin A with model membranes: implications for a novel mechanism of action. , 2006, Biochimica et biophysica acta.
[34] R. Hancock,et al. Solution structure and interaction of the antimicrobial polyphemusins with lipid membranes. , 2005, Biochemistry.
[35] Hongliang Lan,et al. Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1. , 2006, Biochemical and biophysical research communications.
[36] Eric Vives,et al. Cell-penetrating Peptides , 2003, The Journal of Biological Chemistry.
[37] E Neumann,et al. Electric field mediated gene transfer. , 1982, Biochemical and biophysical research communications.
[38] R. Houghten,et al. Hemolytic and antimicrobial activities of the twenty-four individual omission analogues of melittin. , 1991, Biochemistry.
[39] H. Vogel,et al. Lactoferricin , 2005, Cellular and Molecular Life Sciences.
[40] T. Bártfai,et al. VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. , 2001, Experimental cell research.
[41] H. Aoyagi,et al. Interaction of the fragments characteristic of bactenecin 7 with phospholipid bilayers and their antimicrobial activity. , 1995, Journal of biochemistry.
[42] Ülo Langel,et al. Cell entry and antimicrobial properties of eukaryotic cell‐ penetrating peptides , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[43] R. Hancock,et al. Interaction of Cationic Antimicrobial Peptides with Model Membranes* , 2001, The Journal of Biological Chemistry.
[44] Carl O. Pabo,et al. Cellular uptake of the tat protein from human immunodeficiency virus , 1988, Cell.
[45] R. Gennaro,et al. Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils , 1989, Infection and immunity.
[46] R. Hancock,et al. Cationic peptides: effectors in innate immunity and novel antimicrobials. , 2001, The Lancet. Infectious diseases.
[47] R. Jelinek,et al. Membrane interactions of host-defense peptides studied in model systems. , 2005, Current protein & peptide science.
[48] T. Mirzabekov,et al. Membrane channel formation by antimicrobial protegrins. , 1999, Biochimica et biophysica acta.
[49] J. Larrick,et al. The solution structure of the active domain of CAP18 — a lipopolysaccharide binding protein from rabbit leukocytes , 1995, FEBS letters.
[50] S. Shin,et al. Effects of dimerization of the cell‐penetrating peptide Tat analog on antimicrobial activity and mechanism of bactericidal action , 2009, Journal of peptide science : an official publication of the European Peptide Society.
[51] J. Tam,et al. Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7. , 2002, Biochemistry.
[52] André Pèlegrin,et al. Cell-penetrating and cell-targeting peptides in drug delivery. , 2008, Biochimica et biophysica acta.
[53] Karolin F Meyer,et al. Quantum dot-carrier peptide conjugates suitable for imaging and delivery applications. , 2008, Bioconjugate chemistry.
[54] Ralph Weissleder,et al. Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. , 2002, Bioconjugate chemistry.
[55] N. Fujii,et al. Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore. , 1995, Biochemistry.
[56] U. Schatzschneider,et al. Cymantrene conjugation modulates the intracellular distribution and induces high cytotoxicity of a cell-penetrating peptide. , 2008, Chemical communications.
[57] R I Lehrer,et al. Antimicrobial peptides in mammalian and insect host defence. , 1999, Current opinion in immunology.
[58] I. Mäger,et al. In vivo biodistribution and efficacy of peptide mediated delivery. , 2010, Trends in pharmacological sciences.
[59] C. Rousselle,et al. New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. , 2000, Molecular pharmacology.
[60] K. Merz,et al. Influence of the metal complex-to-peptide linker on the synthesis and properties of bioactive CpMn(CO)3 peptide conjugates. , 2010, Dalton transactions.
[61] B. Wiesner,et al. Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. , 1998, Biochimica et biophysica acta.
[62] M. Mutter,et al. Retention behaviour of a template-assembled synthetic protein and its amphiphilic building blocks on reversed-phase columns. , 1991, Journal of chromatography.
[63] B. Rothen‐Rutishauser,et al. Novel peptide conjugates for tumor-specific chemotherapy. , 2001, Journal of medicinal chemistry.
[64] Miguel A R B Castanho,et al. Cell-penetrating peptides and antimicrobial peptides: how different are they? , 2006, The Biochemical journal.
[65] D. Hultmark,et al. Sequence and specificity of two antibacterial proteins involved in insect immunity , 1981, Nature.
[66] Jeremy C Simpson,et al. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[67] Ű. Langel,et al. CPP-protein constructs induce a population of non-acidic vesicles during trafficking through endo-lysosomal pathway. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[68] K. Matsuzaki. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. , 1999, Biochimica et biophysica acta.
[69] Isabel D. Alves,et al. Translocation and Endocytosis for Cell-penetrating Peptide Internalization , 2009, The Journal of Biological Chemistry.
[70] R. Hancock,et al. The relationship between peptide structure and antibacterial activity , 2003, Peptides.
[71] Mechanism and kinetics of delta-lysin interaction with phospholipid vesicles. , 2002, Biochemistry.
[72] Y. Shai,et al. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. , 1999, The Biochemical journal.
[73] Ű. Langel,et al. Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide. , 2006, Biochemical pharmacology.
[74] C. B. Park,et al. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. , 1998, Biochemical and biophysical research communications.
[75] Ű. Langel,et al. Cell-penetrating peptides--a brief introduction. , 2006, Biochimica et biophysica acta.
[76] T. Bártfai,et al. Cellular translocation of proteins by transportan , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[77] R. Hancock,et al. Interaction and Cellular Localization of the Human Host Defense Peptide LL-37 with Lung Epithelial Cells , 2005, Infection and Immunity.
[78] S. González-Chávez,et al. Lactoferrin: structure, function and applications. , 2009, International journal of antimicrobial agents.
[79] Ralph Weissleder,et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.
[80] R. Gust,et al. Protease-activatable organometal-Peptide bioconjugates with enhanced cytotoxicity on cancer cells. , 2010, Bioconjugate chemistry.
[81] Y. Shai,et al. Mode of action of membrane active antimicrobial peptides. , 2002, Biopolymers.
[82] Miguel A R B Castanho,et al. Translocation of beta-galactosidase mediated by the cell-penetrating peptide pep-1 into lipid vesicles and human HeLa cells is driven by membrane electrostatic potential. , 2005, Biochemistry.
[83] Ű. Langel,et al. Cell-penetrating peptides: mechanisms and applications. , 2005, Current pharmaceutical design.
[84] D. Craik,et al. Insect peptides with improved protease‐resistance protect mice against bacterial infection , 2008, Protein science : a publication of the Protein Society.
[85] C. Roumestand,et al. Change in membrane permeability induced by protegrin 1: implication of disulphide bridges for pore formation , 1996, FEBS letters.
[86] S. Lovas,et al. The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. , 2001, Biochemistry.
[87] A. Prochiantz,et al. Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent* , 1996, The Journal of Biological Chemistry.
[88] Alessandro Tossi,et al. Amphipathic, α‐helical antimicrobial peptides , 2000 .
[89] Dong-Kuk Lee,et al. Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. , 2003, Biochemistry.
[90] J. Fiddes,et al. Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity , 1997, Antimicrobial agents and chemotherapy.
[91] T. Ganz,et al. Cathelicidins: a family of endogenous antimicrobial peptides , 2002, Current opinion in hematology.
[92] K. Jeong,et al. Effective antibacterial action of tat (47-58) by increased uptake into bacterial cells in the presence of trypsin. , 2008, Journal of microbiology and biotechnology.
[93] K. Yamauchi,et al. Identification of the bactericidal domain of lactoferrin. , 1992, Biochimica et biophysica acta.
[94] M. Morris,et al. A peptide carrier for the delivery of biologically active proteins into mammalian cells , 2001, Nature Biotechnology.
[95] R. Lehrer,et al. Primate defensins , 2004, Nature Reviews Microbiology.
[96] C. Rousselle,et al. Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity. , 2001, The Journal of pharmacology and experimental therapeutics.
[97] B. Nordén,et al. Dual functions of the human antimicrobial peptide LL-37-target membrane perturbation and host cell cargo delivery. , 2010, Biochimica et biophysica acta.
[98] M. Morris,et al. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. , 2003, Nucleic acids research.
[99] G. W. Vuister,et al. A Cell-penetrating Peptide Derived from Human Lactoferrin with Conformation-dependent Uptake Efficiency , 2009, The Journal of Biological Chemistry.
[100] R. Fischer,et al. Break on through to the Other Side—Biophysics and Cell Biology Shed Light on Cell‐Penetrating Peptides , 2005, Chembiochem : a European journal of chemical biology.
[101] Priscille Brodin,et al. A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus* , 1997, The Journal of Biological Chemistry.
[102] Jindrich Kopecek,et al. Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells. , 2003, Bioconjugate chemistry.
[103] V. Torchilin,et al. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[104] S. Wölfl,et al. Fusion of a Short HA2-Derived Peptide Sequence to Cell-Penetrating Peptides Improves Cytosolic Uptake, but Enhances Cytotoxic Activity , 2009, Pharmaceuticals.
[105] Ü. Langel,et al. Cell-Penetrating Peptides , 2000, Methods in Molecular Biology.
[106] E. Vivés,et al. TAT peptide internalization: seeking the mechanism of entry. , 2003, Current protein & peptide science.
[107] B. Lebleu,et al. Cell penetrating peptides: overview and applications to the delivery of oligonucleotides , 2010, Cellular and Molecular Life Sciences.
[108] B. Wiesner,et al. Structural requirements for cellular uptake of α‐helical amphipathic peptides , 1999 .
[109] F. Separovic,et al. Membrane interactions of antimicrobial peptides from Australian frogs. , 2006, Biochimica et biophysica acta.
[110] M. Morris,et al. Insight into the mechanism of internalization of the cell-penetrating carrier peptide Pep-1 through conformational analysis. , 2004, Biochemistry.
[111] C. Contag,et al. Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters , 2008, Proceedings of the National Academy of Sciences.
[112] M. Hällbrink,et al. Quantitatively determined uptake of cell-penetrating peptides in non-mammalian cells with an evaluation of degradation and antimicrobial effects , 2006, Peptides.
[113] A. Tossi,et al. Amphipathic, alpha-helical antimicrobial peptides. , 2000, Biopolymers.
[114] P. Tempst,et al. Functional and chemical characterization of Hymenoptaecin, an antibacterial polypeptide that is infection-inducible in the honeybee (Apis mellifera). , 1993, The Journal of biological chemistry.
[115] Robert Bals,et al. Antimicrobial Peptides , 2012, Drugs.
[116] S. Yonehara,et al. Translocation of Analogues of the Antimicrobial Peptides Magainin and Buforin across Human Cell Membranes* , 2003, The Journal of Biological Chemistry.
[117] A. Pokorny,et al. Mechanism and Kinetics of δ-Lysin Interaction with Phospholipid Vesicles† , 2002 .